chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Herpes zoster, Infection, Neuralgia
Clinical narrative: Tested positive on Shingles; Pain in her sciatica/shooting pain that she initially thought was sciatica; Sore arm; Chills; Fever; Shooting pain; nerve pain; I also had a little bit of infection; I was suffering from Sciatica because my right hip and leg was sore; I was suffering from Sciatica because my right hip and leg was sore; This is a spontaneous report from a Pfizer-sponsored program  a contactable consumer (Patient). A 59-years-old female patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EK9231), via an unspecified route of administration on 27Jan2021 as SINGLE DOSE for covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  On an unspecified, The patient experienced tested positive on shingles (herpes zoster) , pain in her sciatica/shooting pain that she initially thought was sciatica (sciatica) , sore arm (pain in extremity), chills (chills), fever (pyrexia), shooting pain (pain), nerve pain (neuralgia) , i also had a little bit of infection (infection), i was suffering from sciatica because my right hip and leg was sore (arthralgia), i was suffering from sciatica because my right hip and leg was sore (pain in extremity). The patient had experienced pain in her sciatica and tested positive on Shingles after receiving the 1st dose. Dates for The lesions they never really went anywhere, they sort of popped-up and then they dried out within about 3 to 4 days so they never blistered they never opened up. because my right hip and leg was sore. Saturday after getting shot I ended up finding out I had Shingles because I broke out. I went to the emergency room so they put me on Valtrex and they put me on Keflex because it looks like I also had a little bit of infection so I just finished up those medicines and I am due to have my second Covid shot next Wednesday and wondering since I had shingles since I had shingles, should I postponed that second shot or is it safe for me to get it. The outcome of the events was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Pyrexia, Sciatica
Clinical narrative: Tested positive on Shingles; Pain in her sciatica/shooting pain that she initially thought was sciatica; Sore arm; Chills; Fever; Shooting pain; nerve pain; I also had a little bit of infection; I was suffering from Sciatica because my right hip and leg was sore; I was suffering from Sciatica because my right hip and leg was sore; This is a spontaneous report from a Pfizer-sponsored program  a contactable consumer (Patient). A 59-years-old female patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EK9231), via an unspecified route of administration on 27Jan2021 as SINGLE DOSE for covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  On an unspecified, The patient experienced tested positive on shingles (herpes zoster) , pain in her sciatica/shooting pain that she initially thought was sciatica (sciatica) , sore arm (pain in extremity), chills (chills), fever (pyrexia), shooting pain (pain), nerve pain (neuralgia) , i also had a little bit of infection (infection), i was suffering from sciatica because my right hip and leg was sore (arthralgia), i was suffering from sciatica because my right hip and leg was sore (pain in extremity). The patient had experienced pain in her sciatica and tested positive on Shingles after receiving the 1st dose. Dates for The lesions they never really went anywhere, they sort of popped-up and then they dried out within about 3 to 4 days so they never blistered they never opened up. because my right hip and leg was sore. Saturday after getting shot I ended up finding out I had Shingles because I broke out. I went to the emergency room so they put me on Valtrex and they put me on Keflex because it looks like I also had a little bit of infection so I just finished up those medicines and I am due to have my second Covid shot next Wednesday and wondering since I had shingles since I had shingles, should I postponed that second shot or is it safe for me to get it. The outcome of the events was unknown.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Blood test, Chills, Diplopia, Disorientation
Clinical narrative: fatigue from waist to feet posteriorly and bilaterally; gfr 47; headache; nausea; dizziness; facial tingling/bilateral hand and foot tingling; double vision; disorientation; joint pain; orthostatic hypotension; chills; photophobic/photophobia; This is a spontaneous report from a contactable nurse (patient). A 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 2 via an unspecified route of administration, administered in left deltoid on 26Jan2021 15:00 (Batch/Lot Number: EL1283) as single dose for covid-19 immunisation. The first dose was received on 05Jan2021 15:00 (lot number: EL1284) on the left arm. Medical history included herpes simplex virus (HSV), Superior Oblique Myokymia, and Lyme Disease; from an unspecified date and unknown if ongoing. Patient was not pregnant. Concomitant medications included calcium citrate, magnesium citrate (CAL/MAG CITRATE), ergocalciferol (VIT D), fish oil (OMEGA 3), and paracetamol (TYLENOL). The patient previously took VICODIN and flu vaccine as a child, and experienced allergies. The patient experienced headache, nausea, dizziness, facial tingling, double vision, disorientation, joint pain, orthostatic hypotension, chills, photophobic from 27Jan2021 05:00. On 02Feb2021, she experienced dizziness, headache, nausea, photophobia, facial tingling, bilateral hand and foot tingling, GFR 47 all other CBC, cmp normal. There was headache, nausea, photophobia, facial tingling on 07Feb2021 and on 10Feb2021, tingling and fatigue from waist to feet posteriorly and bilaterally. She had lab test drawn and blood work done when she was sick and her GFR came back as 47, so everything else was normal, and her GFR was 47 which was out of range. On 03Feb2021 was the first test and it was 2 weeks that she had to repeat test just to make sure it was back in normal range which it was. Thee patient was still experiencing the events but 'not as bad', and stated she can still function. Her side effects were improving but she still have a daily headache and paresthesia. The events resulted in physician/ healthcare professional visit. Patient was recovering from the events. ZOFRAN was given as treatment for the events. Patient stated she takes Tylenol but her doctor want her not to take medication for a while but she had to take Tylenol. Patient had no covid prior to vaccination and has been tested (nasal swab) post vaccination on 29Jan2021 with negative results.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Fatigue, Full blood count, Glomerular filtration rate, Glomerular filtration rate decreased
Clinical narrative: fatigue from waist to feet posteriorly and bilaterally; gfr 47; headache; nausea; dizziness; facial tingling/bilateral hand and foot tingling; double vision; disorientation; joint pain; orthostatic hypotension; chills; photophobic/photophobia; This is a spontaneous report from a contactable nurse (patient). A 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 2 via an unspecified route of administration, administered in left deltoid on 26Jan2021 15:00 (Batch/Lot Number: EL1283) as single dose for covid-19 immunisation. The first dose was received on 05Jan2021 15:00 (lot number: EL1284) on the left arm. Medical history included herpes simplex virus (HSV), Superior Oblique Myokymia, and Lyme Disease; from an unspecified date and unknown if ongoing. Patient was not pregnant. Concomitant medications included calcium citrate, magnesium citrate (CAL/MAG CITRATE), ergocalciferol (VIT D), fish oil (OMEGA 3), and paracetamol (TYLENOL). The patient previously took VICODIN and flu vaccine as a child, and experienced allergies. The patient experienced headache, nausea, dizziness, facial tingling, double vision, disorientation, joint pain, orthostatic hypotension, chills, photophobic from 27Jan2021 05:00. On 02Feb2021, she experienced dizziness, headache, nausea, photophobia, facial tingling, bilateral hand and foot tingling, GFR 47 all other CBC, cmp normal. There was headache, nausea, photophobia, facial tingling on 07Feb2021 and on 10Feb2021, tingling and fatigue from waist to feet posteriorly and bilaterally. She had lab test drawn and blood work done when she was sick and her GFR came back as 47, so everything else was normal, and her GFR was 47 which was out of range. On 03Feb2021 was the first test and it was 2 weeks that she had to repeat test just to make sure it was back in normal range which it was. Thee patient was still experiencing the events but 'not as bad', and stated she can still function. Her side effects were improving but she still have a daily headache and paresthesia. The events resulted in physician/ healthcare professional visit. Patient was recovering from the events. ZOFRAN was given as treatment for the events. Patient stated she takes Tylenol but her doctor want her not to take medication for a while but she had to take Tylenol. Patient had no covid prior to vaccination and has been tested (nasal swab) post vaccination on 29Jan2021 with negative results.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Metabolic function test, Nausea, Orthostatic hypotension, Paraesthesia
Clinical narrative: fatigue from waist to feet posteriorly and bilaterally; gfr 47; headache; nausea; dizziness; facial tingling/bilateral hand and foot tingling; double vision; disorientation; joint pain; orthostatic hypotension; chills; photophobic/photophobia; This is a spontaneous report from a contactable nurse (patient). A 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 2 via an unspecified route of administration, administered in left deltoid on 26Jan2021 15:00 (Batch/Lot Number: EL1283) as single dose for covid-19 immunisation. The first dose was received on 05Jan2021 15:00 (lot number: EL1284) on the left arm. Medical history included herpes simplex virus (HSV), Superior Oblique Myokymia, and Lyme Disease; from an unspecified date and unknown if ongoing. Patient was not pregnant. Concomitant medications included calcium citrate, magnesium citrate (CAL/MAG CITRATE), ergocalciferol (VIT D), fish oil (OMEGA 3), and paracetamol (TYLENOL). The patient previously took VICODIN and flu vaccine as a child, and experienced allergies. The patient experienced headache, nausea, dizziness, facial tingling, double vision, disorientation, joint pain, orthostatic hypotension, chills, photophobic from 27Jan2021 05:00. On 02Feb2021, she experienced dizziness, headache, nausea, photophobia, facial tingling, bilateral hand and foot tingling, GFR 47 all other CBC, cmp normal. There was headache, nausea, photophobia, facial tingling on 07Feb2021 and on 10Feb2021, tingling and fatigue from waist to feet posteriorly and bilaterally. She had lab test drawn and blood work done when she was sick and her GFR came back as 47, so everything else was normal, and her GFR was 47 which was out of range. On 03Feb2021 was the first test and it was 2 weeks that she had to repeat test just to make sure it was back in normal range which it was. Thee patient was still experiencing the events but 'not as bad', and stated she can still function. Her side effects were improving but she still have a daily headache and paresthesia. The events resulted in physician/ healthcare professional visit. Patient was recovering from the events. ZOFRAN was given as treatment for the events. Patient stated she takes Tylenol but her doctor want her not to take medication for a while but she had to take Tylenol. Patient had no covid prior to vaccination and has been tested (nasal swab) post vaccination on 29Jan2021 with negative results.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Photophobia, SARS-CoV-2 test
Clinical narrative: fatigue from waist to feet posteriorly and bilaterally; gfr 47; headache; nausea; dizziness; facial tingling/bilateral hand and foot tingling; double vision; disorientation; joint pain; orthostatic hypotension; chills; photophobic/photophobia; This is a spontaneous report from a contactable nurse (patient). A 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 2 via an unspecified route of administration, administered in left deltoid on 26Jan2021 15:00 (Batch/Lot Number: EL1283) as single dose for covid-19 immunisation. The first dose was received on 05Jan2021 15:00 (lot number: EL1284) on the left arm. Medical history included herpes simplex virus (HSV), Superior Oblique Myokymia, and Lyme Disease; from an unspecified date and unknown if ongoing. Patient was not pregnant. Concomitant medications included calcium citrate, magnesium citrate (CAL/MAG CITRATE), ergocalciferol (VIT D), fish oil (OMEGA 3), and paracetamol (TYLENOL). The patient previously took VICODIN and flu vaccine as a child, and experienced allergies. The patient experienced headache, nausea, dizziness, facial tingling, double vision, disorientation, joint pain, orthostatic hypotension, chills, photophobic from 27Jan2021 05:00. On 02Feb2021, she experienced dizziness, headache, nausea, photophobia, facial tingling, bilateral hand and foot tingling, GFR 47 all other CBC, cmp normal. There was headache, nausea, photophobia, facial tingling on 07Feb2021 and on 10Feb2021, tingling and fatigue from waist to feet posteriorly and bilaterally. She had lab test drawn and blood work done when she was sick and her GFR came back as 47, so everything else was normal, and her GFR was 47 which was out of range. On 03Feb2021 was the first test and it was 2 weeks that she had to repeat test just to make sure it was back in normal range which it was. Thee patient was still experiencing the events but 'not as bad', and stated she can still function. Her side effects were improving but she still have a daily headache and paresthesia. The events resulted in physician/ healthcare professional visit. Patient was recovering from the events. ZOFRAN was given as treatment for the events. Patient stated she takes Tylenol but her doctor want her not to take medication for a while but she had to take Tylenol. Patient had no covid prior to vaccination and has been tested (nasal swab) post vaccination on 29Jan2021 with negative results.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Central venous catheterisation, Confusional state, Dizziness, Headache
Clinical narrative: fatigue from waist to feet posteriorly and bilaterally; gfr 47; headache; nausea; dizziness; facial tingling/bilateral hand and foot tingling; double vision; disorientation; joint pain; orthostatic hypotension; chills; photophobic/photophobia; This is a spontaneous report from a contactable nurse (patient). A 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 2 via an unspecified route of administration, administered in left deltoid on 26Jan2021 15:00 (Batch/Lot Number: EL1283) as single dose for covid-19 immunisation. The first dose was received on 05Jan2021 15:00 (lot number: EL1284) on the left arm. Medical history included herpes simplex virus (HSV), Superior Oblique Myokymia, and Lyme Disease; from an unspecified date and unknown if ongoing. Patient was not pregnant. Concomitant medications included calcium citrate, magnesium citrate (CAL/MAG CITRATE), ergocalciferol (VIT D), fish oil (OMEGA 3), and paracetamol (TYLENOL). The patient previously took VICODIN and flu vaccine as a child, and experienced allergies. The patient experienced headache, nausea, dizziness, facial tingling, double vision, disorientation, joint pain, orthostatic hypotension, chills, photophobic from 27Jan2021 05:00. On 02Feb2021, she experienced dizziness, headache, nausea, photophobia, facial tingling, bilateral hand and foot tingling, GFR 47 all other CBC, cmp normal. There was headache, nausea, photophobia, facial tingling on 07Feb2021 and on 10Feb2021, tingling and fatigue from waist to feet posteriorly and bilaterally. She had lab test drawn and blood work done when she was sick and her GFR came back as 47, so everything else was normal, and her GFR was 47 which was out of range. On 03Feb2021 was the first test and it was 2 weeks that she had to repeat test just to make sure it was back in normal range which it was. Thee patient was still experiencing the events but 'not as bad', and stated she can still function. Her side effects were improving but she still have a daily headache and paresthesia. The events resulted in physician/ healthcare professional visit. Patient was recovering from the events. ZOFRAN was given as treatment for the events. Patient stated she takes Tylenol but her doctor want her not to take medication for a while but she had to take Tylenol. Patient had no covid prior to vaccination and has been tested (nasal swab) post vaccination on 29Jan2021 with negative results.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Laboratory test, Metabolic function test, Nausea, Orthostatic hypotension
Clinical narrative: fatigue from waist to feet posteriorly and bilaterally; gfr 47; headache; nausea; dizziness; facial tingling/bilateral hand and foot tingling; double vision; disorientation; joint pain; orthostatic hypotension; chills; photophobic/photophobia; This is a spontaneous report from a contactable nurse (patient). A 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 2 via an unspecified route of administration, administered in left deltoid on 26Jan2021 15:00 (Batch/Lot Number: EL1283) as single dose for covid-19 immunisation. The first dose was received on 05Jan2021 15:00 (lot number: EL1284) on the left arm. Medical history included herpes simplex virus (HSV), Superior Oblique Myokymia, and Lyme Disease; from an unspecified date and unknown if ongoing. Patient was not pregnant. Concomitant medications included calcium citrate, magnesium citrate (CAL/MAG CITRATE), ergocalciferol (VIT D), fish oil (OMEGA 3), and paracetamol (TYLENOL). The patient previously took VICODIN and flu vaccine as a child, and experienced allergies. The patient experienced headache, nausea, dizziness, facial tingling, double vision, disorientation, joint pain, orthostatic hypotension, chills, photophobic from 27Jan2021 05:00. On 02Feb2021, she experienced dizziness, headache, nausea, photophobia, facial tingling, bilateral hand and foot tingling, GFR 47 all other CBC, cmp normal. There was headache, nausea, photophobia, facial tingling on 07Feb2021 and on 10Feb2021, tingling and fatigue from waist to feet posteriorly and bilaterally. She had lab test drawn and blood work done when she was sick and her GFR came back as 47, so everything else was normal, and her GFR was 47 which was out of range. On 03Feb2021 was the first test and it was 2 weeks that she had to repeat test just to make sure it was back in normal range which it was. Thee patient was still experiencing the events but 'not as bad', and stated she can still function. Her side effects were improving but she still have a daily headache and paresthesia. The events resulted in physician/ healthcare professional visit. Patient was recovering from the events. ZOFRAN was given as treatment for the events. Patient stated she takes Tylenol but her doctor want her not to take medication for a while but she had to take Tylenol. Patient had no covid prior to vaccination and has been tested (nasal swab) post vaccination on 29Jan2021 with negative results.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in jaw, Paraesthesia, Photophobia, Restless legs syndrome, Tremor
Clinical narrative: fatigue from waist to feet posteriorly and bilaterally; gfr 47; headache; nausea; dizziness; facial tingling/bilateral hand and foot tingling; double vision; disorientation; joint pain; orthostatic hypotension; chills; photophobic/photophobia; This is a spontaneous report from a contactable nurse (patient). A 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 2 via an unspecified route of administration, administered in left deltoid on 26Jan2021 15:00 (Batch/Lot Number: EL1283) as single dose for covid-19 immunisation. The first dose was received on 05Jan2021 15:00 (lot number: EL1284) on the left arm. Medical history included herpes simplex virus (HSV), Superior Oblique Myokymia, and Lyme Disease; from an unspecified date and unknown if ongoing. Patient was not pregnant. Concomitant medications included calcium citrate, magnesium citrate (CAL/MAG CITRATE), ergocalciferol (VIT D), fish oil (OMEGA 3), and paracetamol (TYLENOL). The patient previously took VICODIN and flu vaccine as a child, and experienced allergies. The patient experienced headache, nausea, dizziness, facial tingling, double vision, disorientation, joint pain, orthostatic hypotension, chills, photophobic from 27Jan2021 05:00. On 02Feb2021, she experienced dizziness, headache, nausea, photophobia, facial tingling, bilateral hand and foot tingling, GFR 47 all other CBC, cmp normal. There was headache, nausea, photophobia, facial tingling on 07Feb2021 and on 10Feb2021, tingling and fatigue from waist to feet posteriorly and bilaterally. She had lab test drawn and blood work done when she was sick and her GFR came back as 47, so everything else was normal, and her GFR was 47 which was out of range. On 03Feb2021 was the first test and it was 2 weeks that she had to repeat test just to make sure it was back in normal range which it was. Thee patient was still experiencing the events but 'not as bad', and stated she can still function. Her side effects were improving but she still have a daily headache and paresthesia. The events resulted in physician/ healthcare professional visit. Patient was recovering from the events. ZOFRAN was given as treatment for the events. Patient stated she takes Tylenol but her doctor want her not to take medication for a while but she had to take Tylenol. Patient had no covid prior to vaccination and has been tested (nasal swab) post vaccination on 29Jan2021 with negative results.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Illness
Clinical narrative: Dizziness I got very dizzy; Nausea; Headache; Tired; Chills; Sick; she did not feel well for 2 days, stated that it was hard for her to get off the bed; This is a spontaneous report from a contactable consumer (Patient).  A 90-year-old female received first dose of the BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: UNKNOWN), via an unspecified route of administration on 23Jan2021, as SINGLE DOSE for COVID-19 immunisation. The patient medical history and concomitant medication were not reported. On the same date, the patient had side effects right after she got home, one hour after the shot, she walked in the house and that's when she had side effects right away, first side effect was dizziness she got very dizzy, then she got nausea, then she got a headache, she was very tired, she had a chills and she did not feel well for 2 days, stated that it was hard for her to get off the bed. Patient stated that she got a shot on Saturday (23Jan2021) was sick right away after she was in bed Saturday and Sunday and Monday started to feel a little bit better. Patient notified her doctor about her side effects. Patient asked that unusual to get side effects after first dose. Is that mean that she will have the same side effects on second shot. Patient stated that most of her friends and the people she know did not have a side effects after first dose. She stated that she was very susceptible to medications, she did not react well to medications. It was very rare whoever she spoke to did not have reaction to the first dose of vaccine some people that she knew had a reaction to the second (dose of the vaccine) but when she told them that she had reaction to the first (dose) they thought that she was making it up because most of them did not have reaction to first just to the second. At the time of this report Sickness was recovering and outcome other events was unknown.   Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Nausea
Clinical narrative: Dizziness I got very dizzy; Nausea; Headache; Tired; Chills; Sick; she did not feel well for 2 days, stated that it was hard for her to get off the bed; This is a spontaneous report from a contactable consumer (Patient).  A 90-year-old female received first dose of the BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: UNKNOWN), via an unspecified route of administration on 23Jan2021, as SINGLE DOSE for COVID-19 immunisation. The patient medical history and concomitant medication were not reported. On the same date, the patient had side effects right after she got home, one hour after the shot, she walked in the house and that's when she had side effects right away, first side effect was dizziness she got very dizzy, then she got nausea, then she got a headache, she was very tired, she had a chills and she did not feel well for 2 days, stated that it was hard for her to get off the bed. Patient stated that she got a shot on Saturday (23Jan2021) was sick right away after she was in bed Saturday and Sunday and Monday started to feel a little bit better. Patient notified her doctor about her side effects. Patient asked that unusual to get side effects after first dose. Is that mean that she will have the same side effects on second shot. Patient stated that most of her friends and the people she know did not have a side effects after first dose. She stated that she was very susceptible to medications, she did not react well to medications. It was very rare whoever she spoke to did not have reaction to the first dose of vaccine some people that she knew had a reaction to the second (dose of the vaccine) but when she told them that she had reaction to the first (dose) they thought that she was making it up because most of them did not have reaction to first just to the second. At the time of this report Sickness was recovering and outcome other events was unknown.   Information on the lot/batch number has been requested.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; The initial case was missing the following minimum criteria: adverse event. Upon receipt of follow-up information on (29MAR2021), this case now contains all required information to be considered valid.  This is a Spontaneous report from a Pfizer sponsored program. A contactable 80-years-old patient of an unspecified gender reported that received bnt162b2 (BNT162B2, Solution for injection), dose 1 intramuscular, administered in Arm Right on 27Jan2021 (Batch/Lot Number: EL9265) as SINGLE DOSE, dose 2 intramuscular, administered in Arm Right on 24Feb2021 (Batch/Lot Number: EN6200) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced sore arm (pain in extremity) on an unspecified date. The action taken in response to the event for bnt162b2 was not applicable. The outcome of the event was reported as unknown.  No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Pyrexia, Vomiting
Clinical narrative: Vomiting; Headache; Mild Fever; This is a spontaneous report from a contactable other-HCP (patient herself). A 57-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EL9261), via an unspecified route of administration in left arm on 11Feb2021 at 10:00 (at the age of 57-years-old) as single dose for covid-19 immunization. Patient was not pregnant at the time of vaccination. Medical history included patient was allergic to Sulfa Based medications, Zythromycin. The patient concomitant medications were not reported. On 11Feb2021 at 10.30, patient experienced vomiting, headache, mild fever. The patient took vaccine at Workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not take any other medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 and not tested for COVID-19 since the vaccination. The outcome of all the events was reported as not recovered.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Headache, Nausea, Pain, Respiratory tract congestion
Clinical narrative: Vomiting; Headache; Mild Fever; This is a spontaneous report from a contactable other-HCP (patient herself). A 57-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EL9261), via an unspecified route of administration in left arm on 11Feb2021 at 10:00 (at the age of 57-years-old) as single dose for covid-19 immunization. Patient was not pregnant at the time of vaccination. Medical history included patient was allergic to Sulfa Based medications, Zythromycin. The patient concomitant medications were not reported. On 11Feb2021 at 10.30, patient experienced vomiting, headache, mild fever. The patient took vaccine at Workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not take any other medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 and not tested for COVID-19 since the vaccination. The outcome of all the events was reported as not recovered.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: Vomiting; Headache; Mild Fever; This is a spontaneous report from a contactable other-HCP (patient herself). A 57-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EL9261), via an unspecified route of administration in left arm on 11Feb2021 at 10:00 (at the age of 57-years-old) as single dose for covid-19 immunization. Patient was not pregnant at the time of vaccination. Medical history included patient was allergic to Sulfa Based medications, Zythromycin. The patient concomitant medications were not reported. On 11Feb2021 at 10.30, patient experienced vomiting, headache, mild fever. The patient took vaccine at Workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not take any other medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 and not tested for COVID-19 since the vaccination. The outcome of all the events was reported as not recovered.
Sex: F
Vaccine: COVID19
Symptoms: Neck pain
Clinical narrative: Little pain in the right side of her neck; This is an initial spontaneous report from a Pfizer-sponsored program contactable consumer (patient). A-70-year-old female patient received BNT162B2 (BNT162B2, Formulation: solution for injection, Batch/Lot number was not reported) second dose via an unspecified route of administration, administered in right arm and first dose administered in right arm as single dose for COVID-19 immunization. First vaccine was administered by a pharmacist and was middle of arm, second dose was by an RN and was administered higher in the same arm, caller states after second vaccine she had a little pain in the right side of her neck, also watches a lot of TV and saw something about vaccinations at a 90 degree angle, relayed PMI number and transferred long hold time, will fax AE to Pfizer.  The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2
Clinical narrative: she was exposed to someone who is Covid-19 positive; This is a spontaneous report from a contactable consumer via medical information team. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 27Jan2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. patient received the 1st dose of the Pfizer-BioNTech Covid-19 Vaccine on 27Jan2021 and was scheduled to receive the 2nd dose on 17Feb2021. However, she said that she was exposed to a co-worker who tested positive for Covid-19. She wants to know what she should do, and if she should still go ahead and get the 2nd dose on 17Feb2021. The outcome of the event was unknown.  Information about lot and batch number was requested.  Follow-up attempts are completed. No further information is expected.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Confusional state, Pruritus, Respiratory disorder, Throat irritation
Clinical narrative: started to itch; Scratchy throat; Mental confusion; tightness in throat; Her throat tightening made her anxious and her respiratory status worse; Her throat tightening made her anxious and her respiratory status worse; This is a spontaneous report from a contactable consumer. A 74-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL9262), via an unspecified route of administration, at the age of 74 years, administered on the left arm on 08Feb2021 12:45 at a SINGLE DOSE for covid-19 immunisation. Medical history included ongoing hypersensitivity. Additional Information for Other Conditions: medications, cloves, spices, MSG, processed foods and she can't take any antibiotics. There were no concomitant medications. The patient wanted to report a less severe reaction she experienced within 10 minutes of the first dose 08Feb2021. After her vaccine within 10 minutes, she started to itch. The patient had a scratchy throat, mental confusion, tightness in her throat. The tightness in her throat she usually experiences with clove, food allergies and antibiotics. She was familiar with what was happening. The side effects did go away. They asked her to stay 30 minutes. As soon as she left, she took one Benadryl and 10 min later she took a second one. Then, it subsided. Her itching did go into the next day. Her throat tightening made her anxious and her respiratory status worse. It happened so quick. Her first concern was conflicting facts sheets in regards to taking the second dose. The patient wanted to know what was recommended. Should she take the second dose. She has never had anaphylaxis so she doesn't have an Epipen. She can take Benadryl which has gotten her out of more severe responses before. Therapeutic measures (Benadryl) were taken as a result of the events. The outcome of the event itch was recovered on 09Feb2021 while other events were recovered on 08Feb2021.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Throat tightness
Clinical narrative: started to itch; Scratchy throat; Mental confusion; tightness in throat; Her throat tightening made her anxious and her respiratory status worse; Her throat tightening made her anxious and her respiratory status worse; This is a spontaneous report from a contactable consumer. A 74-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL9262), via an unspecified route of administration, at the age of 74 years, administered on the left arm on 08Feb2021 12:45 at a SINGLE DOSE for covid-19 immunisation. Medical history included ongoing hypersensitivity. Additional Information for Other Conditions: medications, cloves, spices, MSG, processed foods and she can't take any antibiotics. There were no concomitant medications. The patient wanted to report a less severe reaction she experienced within 10 minutes of the first dose 08Feb2021. After her vaccine within 10 minutes, she started to itch. The patient had a scratchy throat, mental confusion, tightness in her throat. The tightness in her throat she usually experiences with clove, food allergies and antibiotics. She was familiar with what was happening. The side effects did go away. They asked her to stay 30 minutes. As soon as she left, she took one Benadryl and 10 min later she took a second one. Then, it subsided. Her itching did go into the next day. Her throat tightening made her anxious and her respiratory status worse. It happened so quick. Her first concern was conflicting facts sheets in regards to taking the second dose. The patient wanted to know what was recommended. Should she take the second dose. She has never had anaphylaxis so she doesn't have an Epipen. She can take Benadryl which has gotten her out of more severe responses before. Therapeutic measures (Benadryl) were taken as a result of the events. The outcome of the event itch was recovered on 09Feb2021 while other events were recovered on 08Feb2021.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash erythematous
Clinical narrative: 9 days after getting the series I began to develop a Mobiliform erythmatous rash with intense itching. Started on my forearms and then spread up, trunk, back and legs. No relief with otc products.; 9 days after getting the series I began to develop a Mobiliform erythmatous rash with intense itching. Started on my forearms and then spread up, trunk, back and legs. No relief with otc products.; This is a spontaneous report received from a contactable physician (reporting on herself). A 36-years-old female patient received Second dose of BNT162B2 ((BNT162B2, Formulation: Solution for injection, Lot Number: El3249 and Expiration date was not reported) via an unspecified route of administration in Arm Left on 11Jan2021 17:00 as single dose for covid-19 immunisation. Medical history included hypothyroid, covid-19. Patient had no known allergies. Patient had covid prior vaccination. The historical vaccine first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number Eh9899 and Expiry date was not reported), via an unspecified route of administration in Arm Left on 21Dec2020 17:00 for COVID-19 immunization. Concomitant medication(s) included levothyroxine (LEVOTHYROXINE) taken for an unspecified indication, start and stop date were not reported. Patient did not take any other vaccine in four weeks. It was re-ported that 9 days after getting the series she began to develop a Mobiliform erythmatous rash with intense itching. Started on her forearms and then spread up, trunk, back and legs. No relief with otc products. So far on steroid taper and still present coming back as taper is lessening. Itching was intense and rash is diffuse. The outcome of the events was not recovered.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Vaccination site bruising
Clinical narrative: arm got real red and sore; arm got real red and sore; there was a little bruise where the shot was given; This is a spontaneous report from a contactable consumer (patient). A 93-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: Unknown), via an unspecified route of administration on 03Feb2021 as single dose for COVID-19 immunization. Patient had historical vaccine, first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 10Feb2021, the patient experienced arm got real red and sore, there was a little bruise where the shot was given. Patient stated had both Pfizer vaccines and the second on was on 03Feb. She had no side effects until a week later (10Feb) when her arm got real red and sore and there was a little bruise where the shot was given. It lasted a day and today it is better and she feels fine. She is was surprised to have no other symptoms. The outcome of event was recovering.  Information on the batch/lot number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Chills, Dry mouth, Gastrooesophageal reflux disease, Headache
Clinical narrative: experienced acid reflux; aching; chills; hurting head; hurting in her chest; funny and dry feeling in her mouth; a little numbness on her lips; congestion; This is a spontaneous report from a contactable consumer or other non-health care professional via Medical Information Team. A female patient of an Age: 79; Unit: unknown received first and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: unknown) both via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, patient experienced acid reflux, aching, chills, hurting head, hurting in her chest, funny and dry feeling in her mouth, a little numbness on her lips, which patient attributed to the acid reflux and congestion. Patient had already seen a doctor for the acid reflux and got some medicine for it. Patient was also taking Mucinex for her congestion. Patient wanted to know if these were common side effects of the vaccine. Outcome of the events was unknown.  Information on batch/lot number was requested.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Nasal congestion, Pain
Clinical narrative: experienced acid reflux; aching; chills; hurting head; hurting in her chest; funny and dry feeling in her mouth; a little numbness on her lips; congestion; This is a spontaneous report from a contactable consumer or other non-health care professional via Medical Information Team. A female patient of an Age: 79; Unit: unknown received first and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: unknown) both via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, patient experienced acid reflux, aching, chills, hurting head, hurting in her chest, funny and dry feeling in her mouth, a little numbness on her lips, which patient attributed to the acid reflux and congestion. Patient had already seen a doctor for the acid reflux and got some medicine for it. Patient was also taking Mucinex for her congestion. Patient wanted to know if these were common side effects of the vaccine. Outcome of the events was unknown.  Information on batch/lot number was requested.
Sex: F
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: reduction of the pain I had been experiencing since July in my right shoulder joint.; This is a spontaneous report from a contactable consumer (patient). A 81-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration in Arm Left on 21Jan2021 at 08:30 as single dose for COVID-19 immunisation. Medical history included pain I had been experiencing since July in my right shoulder joint from Jul2020. The patient had no known allergies. The patient's concomitant medication(s) included amlodipine besylate 5mg  and atorvastatin 20mg. The patient did not take other vaccine in four weeks. The patient did not had COVID prior to vaccination and did not tested for COVID post vaccination. On 21Jan2021 at 12:00, the patient experienced reduction of the pain she had been experiencing since July in my right shoulder joint. When the patient lifted her right arm and moved it in a counter-clockwise 360 degree circle, the pain had been reduced about 90% and the movement was no longer painful. The joint is not 100% but much improved. The patient was delighted with the result. She wondered if anyone else has experienced any reduction in osteoarthritis pain after receiving Pfizer COVID-19 vaccine. The outcome of the event was unknown.  Information on the Lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Body temperature, Body temperature increased, Cold sweat
Clinical narrative: Clammy; Within 18 minutes, temperature of 99.9; BP 188/82 and as high as 196/88; Odd/metallic taste in throat; Flush; This is a spontaneous report from a non-contactable consumer. This 67-year-old female (Non pregnant) consumer reported for herself that patient received second dose of BNT162B2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, Batch/Lot number: unknown Expiry date: unknown), via an unspecified route of administration in left arm on 03Feb2021 at 10:00 AM, and first dose BNT162B2 (Pfizer covid 19 vaccine solution for injection, Batch/Lot number: unknown Expiry date: unknown) via an unspecified route of administration on unspecified date both as a single dose for COVID-19 immunization. Patient medical history included hypopituitarism, coronary artery disease. Patient other concomitant medication included in two weeks toprolol, amlodipine, levothyroxine, hydrocortizo. Patient had known allergies to 2 shingles vaccine. Patient has not taken any medications within four weeks of vaccination. Patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since the vaccination. Patient experienced within 18 minutes after the vaccination temperature was of 99.9, BP 188/82 and as high as 196/88, odd/metallic taste in throat, flush, clammy on 03Feb2021 at 10:30 AM. No therapeutic measures were taken for the events occurred. The outcome of the events was recovering.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Flushing
Clinical narrative: Clammy; Within 18 minutes, temperature of 99.9; BP 188/82 and as high as 196/88; Odd/metallic taste in throat; Flush; This is a spontaneous report from a non-contactable consumer. This 67-year-old female (Non pregnant) consumer reported for herself that patient received second dose of BNT162B2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, Batch/Lot number: unknown Expiry date: unknown), via an unspecified route of administration in left arm on 03Feb2021 at 10:00 AM, and first dose BNT162B2 (Pfizer covid 19 vaccine solution for injection, Batch/Lot number: unknown Expiry date: unknown) via an unspecified route of administration on unspecified date both as a single dose for COVID-19 immunization. Patient medical history included hypopituitarism, coronary artery disease. Patient other concomitant medication included in two weeks toprolol, amlodipine, levothyroxine, hydrocortizo. Patient had known allergies to 2 shingles vaccine. Patient has not taken any medications within four weeks of vaccination. Patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since the vaccination. Patient experienced within 18 minutes after the vaccination temperature was of 99.9, BP 188/82 and as high as 196/88, odd/metallic taste in throat, flush, clammy on 03Feb2021 at 10:30 AM. No therapeutic measures were taken for the events occurred. The outcome of the events was recovering.  Information on the lot/batch number has been requested.